Literature DB >> 17416611

Molecular basis for PP2A regulatory subunit B56alpha targeting in cardiomyocytes.

Naina Bhasin1, Shane R Cunha, Malkanthi Mudannayake, Marisa S Gigena, Terry B Rogers, Peter J Mohler.   

Abstract

Protein phosphatase 2A (PP2A) is a multifunctional protein phosphatase with critical roles in excitable cell signaling. In the heart, PP2A function is linked with modulation of beta-adrenergic signaling and has been suggested to regulate key ion channels and transporters including Na/Ca exchanger, ryanodine receptor, inositol 1,4,5-trisphosphate receptor, and Na/K ATPase. Although many of the functional roles and molecular targets for PP2A in heart are known, little is established regarding the cellular pathways that localize specific PP2A isoform activities to subcellular sites. We report that the PP2A regulatory subunit B56alpha is an in vivo binding partner for ankyrin-B, an adapter protein required for normal subcellular localization of the Na/Ca exchanger, Na/K ATPase, and inositol 1,4,5-trisphosphate receptor. Ankyrin-B and B56alpha are colocalized and coimmunoprecipitate in primary cardiomyocytes. Using multiple strategies, we identified the structural requirements on B56alpha for ankyrin-B association as a 13 residue motif in the B56alpha COOH terminus not present in other B56 family polypeptides. Finally, we report that reduced ankyrin-B expression in primary ankyrin-B(+/-) cardiomyocytes results in disorganized distribution of B56alpha that can be rescued by exogenous expression of ankyrin-B. These new data implicate ankyrin-B as a critical targeting component for PP2A in heart and identify a new class of signaling proteins targeted by ankyrin polypeptides.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17416611     DOI: 10.1152/ajpheart.00059.2007

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  56 in total

1.  Ankyrin-B reduction enhances Ca spark-mediated SR Ca release promoting cardiac myocyte arrhythmic activity.

Authors:  Emmanuel Camors; Peter J Mohler; Donald M Bers; Sanda Despa
Journal:  J Mol Cell Cardiol       Date:  2012-03-03       Impact factor: 5.000

Review 2.  Defining a new paradigm for human arrhythmia syndromes: phenotypic manifestations of gene mutations in ion channel- and transporter-associated proteins.

Authors:  Michael J Ackerman; Peter J Mohler
Journal:  Circ Res       Date:  2010-08-20       Impact factor: 17.367

3.  Defining new insight into atypical arrhythmia: a computational model of ankyrin-B syndrome.

Authors:  Roseanne M Wolf; Colleen C Mitchell; Matthew D Christensen; Peter J Mohler; Thomas J Hund
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-08-20       Impact factor: 4.733

4.  Ankyrin-B protein in heart failure: identification of a new component of metazoan cardioprotection.

Authors:  Farshid Kashef; Jingdong Li; Patrick Wright; Jedidiah Snyder; Faroug Suliman; Ahmet Kilic; Robert S D Higgins; Mark E Anderson; Philip F Binkley; Thomas J Hund; Peter J Mohler
Journal:  J Biol Chem       Date:  2012-07-09       Impact factor: 5.157

5.  Novel Variant in the ANK2 Membrane-Binding Domain Is Associated With Ankyrin-B Syndrome and Structural Heart Disease in a First Nations Population With a High Rate of Long QT Syndrome.

Authors:  Leigh Anne Swayne; Nathaniel P Murphy; Sirisha Asuri; Lena Chen; Xiaoxue Xu; Sarah McIntosh; Chao Wang; Peter J Lancione; Jason D Roberts; Charles Kerr; Shubhayan Sanatani; Elizabeth Sherwin; Crystal F Kline; Mingjie Zhang; Peter J Mohler; Laura T Arbour
Journal:  Circ Cardiovasc Genet       Date:  2017-01

6.  Exon organization and novel alternative splicing of the human ANK2 gene: implications for cardiac function and human cardiac disease.

Authors:  Shane R Cunha; Solena Le Scouarnec; Jean-Jacques Schott; Peter J Mohler
Journal:  J Mol Cell Cardiol       Date:  2008-08-27       Impact factor: 5.000

7.  Molecular mechanisms underlying cardiac protein phosphatase 2A regulation in heart.

Authors:  Sean T DeGrande; Sean C Little; Derek J Nixon; Patrick Wright; Jedidiah Snyder; Wen Dun; Nathaniel Murphy; Ahmet Kilic; Robert Higgins; Philip F Binkley; Penelope A Boyden; Cynthia A Carnes; Mark E Anderson; Thomas J Hund; Peter J Mohler
Journal:  J Biol Chem       Date:  2012-11-30       Impact factor: 5.157

8.  Regulation of the ankyrin-B-based targeting pathway following myocardial infarction.

Authors:  Thomas J Hund; Patrick J Wright; Wen Dun; Jedidiah S Snyder; Penelope A Boyden; Peter J Mohler
Journal:  Cardiovasc Res       Date:  2008-12-14       Impact factor: 10.787

9.  Molecular determinants for PP2A substrate specificity: charged residues mediate dephosphorylation of tyrosine hydroxylase by the PP2A/B' regulatory subunit.

Authors:  Amit Saraf; Elizabeth A Oberg; Stefan Strack
Journal:  Biochemistry       Date:  2010-02-09       Impact factor: 3.162

10.  Oxidized calmodulin kinase II regulates conduction following myocardial infarction: a computational analysis.

Authors:  Matthew D Christensen; Wen Dun; Penelope A Boyden; Mark E Anderson; Peter J Mohler; Thomas J Hund
Journal:  PLoS Comput Biol       Date:  2009-12-04       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.